Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 480.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.167%)
Open: 490.00
High: 490.00
Low: 490.00
Prev. Close: 490.00
SYS1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

20 Nov 2012 07:00

RNS Number : 5073R
BrainJuicer Group PLC
20 November 2012
 



 

 

 

Press Release 20 November 2012

 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Trading update

 

Innovative, international online market researcher BrainJuicer Group PLC (AIM:BJU) today issues the following update on trading for the financial year ending 31 December, 2012.

 

Revenue for the ten months to the end of October was up 11% over the prior year. However, trading in the final months of 2012 is proving disappointing. In particular, the strong seasonal increase in revenue which the Company has traditionally experienced during the final two months of its financial year, is not occurring in 2012. Revenue during the final quarter is therefore likely to fall significantly below 2011 levels.

 

In our interim results announcement we highlighted the 12% increase in costs during the first half as the Company continued its pursuit of future growth - strengthening its teams, broadening its geographical coverage, building its infrastructure and investing in product innovation. The rate of cost increase during the second half so far has been similar to that seen in the first half.

 

Pre-tax profits for the full year are therefore now expected to be substantially below the £2.8m achieved in 2011. The full year outturn will as always be heavily influenced by the Company's performance in December, and a further update will be issued during the early weeks of 2013.

 

BrainJuicer's financial position remains strong. At the end of October the Company's cash balance was £3.16m. BrainJuicer has no debt.

 

In terms of geography, our recently established businesses in China and Brazil are both delivering growth ahead of our expectations, and Switzerland is having another good year. Profitability in 2012 has been, to varying degrees, disappointing in the UK, Germany and the US, but the Board is confident that these businesses will return to profitable growth. Pending a pick up in revenue growth the Company is curtailing net new recruitment in these markets.

 

The current shortfall in revenue reflects primarily a decline in sales of our more traditional "Twist" products. Crucially, revenue from our innovative, added value "Juicy" products has continued to grow strongly. For the first 10 months of 2012 sales of Juicy products grew by 39%, compared with 22% decline in revenue for Twist products.

 

Perhaps most importantly, we remain convinced of our long term growth potential on the basis of BrainJuicer's approach to market research and the direction the industry is moving in. Traditional assumptions about how people make decisions are being undermined by a growing body of evidence in psychology, neuroscience, sociology and behavioural economics. Research is changing as a result, and BrainJuicer's evolving portfolio of Juicy products is at the forefront of this trend. The pace of change is slower than we would ideally like, but we believe that the barriers will continue to come down as the weight of data and proof continue to validate products such as ours.

 

The Company can be found at www.brainjuicer.com.

 

 

- Ends -

 

 

For further information, please contact:

 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKAKRUWAAAAA
Date   Source Headline
16th Apr 20247:00 amRNSTrading Update
24th Jan 20247:00 amRNSTrading Update
12th Dec 202312:51 pmRNSPresentation via Investor Meet Company
6th Dec 20237:00 amRNSChange of Auditor
6th Dec 20237:00 amRNSInterim Results
24th Oct 20237:00 amRNSTrading Update
27th Sep 20236:00 pmRNSResult of AGM
27th Sep 20237:00 amRNSTrading Update
31st Aug 20237:00 amRNSAnnual Report and Notice of AGM
1st Aug 20237:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2023
31st Jul 20232:00 pmRNSPreliminary Results Presentation
13th Jul 20237:30 amRNSTrading update
30th Jun 20239:00 amRNSResolution of Complaint for Trademark Infringement
28th Jun 202311:00 amRNSHolding(s) in Company
3rd May 20233:15 pmRNSFurther re Result of General Meeting
21st Apr 202311:56 amRNSResult of General Meeting
13th Apr 20237:00 amRNSFurther re Requisitioned General Meeting
12th Apr 20237:00 amRNSTrading Update
5th Apr 202310:45 amRNSNotice of Trading Update
24th Mar 20234:00 pmRNSPosting of Circular and Notice of Requisitioned GM
24th Mar 20237:00 amRNSPosting of Circular and Notice of Requisitioned GM
7th Mar 20237:30 amRNSReceipt of Requisition Notice
28th Feb 202312:50 pmRNSCapital Markets Day
23rd Feb 20237:00 amRNSTrading Update
14th Feb 20237:00 amRNSCapital Markets Day
13th Jan 20232:00 pmRNSDirector/PDMR Shareholding
10th Jan 202310:30 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSDirector/PDMR Shareholding
14th Dec 20224:00 pmRNSDirector/PDMR Shareholding
13th Dec 20226:25 pmRNSDirector/PDMR Shareholding
6th Dec 20224:15 pmRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Results
25th Oct 20227:00 amRNSTrading Update
28th Sep 20226:15 pmRNSResult of AGM
31st Aug 202211:00 amRNSNotice of AGM
31st Aug 20227:00 amRNSDirectorate Change
31st Aug 20227:00 amRNSReview of strategic options
30th Aug 20226:00 pmRNSTransaction in Own Shares
19th Aug 20228:55 amRNSTransaction in Own Shares
3rd Aug 20225:45 pmRNSTransaction in Own Shares
2nd Aug 20223:45 pmRNSTransaction in Own Shares
29th Jul 20229:30 amRNSTransaction in Own Shares
26th Jul 20226:24 pmRNSTransaction in Own Shares
19th Jul 20224:00 pmRNSHolding(s) in Company
19th Jul 20223:00 pmRNSTransaction in Own Shares
18th Jul 20224:30 pmRNSTransaction in Own Shares
15th Jul 20225:15 pmRNSTransaction in Own Shares
12th Jul 20227:00 amRNSShare Buyback Programme
12th Jul 20227:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 MAR 2022
12th Jul 20227:00 amRNSQuarterly Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.